ArticleViruses2020

CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.

Joan Calvet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.